Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Feasibility Study to Assess the Use of SIR-Sphere in Patients With Breast Cancer Who Have Chemotherapy-Resistant Disease in the Liver

NCT00891800 is registered in ClinicalTrials.gov with St. Joseph's Hospital, Florida as lead sponsor.

NCT NCT00891800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Feasibility Study to Assess the Use of SIR-Sphere in Patients With Breast Cancer Who Have Chemotherapy-Resistant Disease in the Liver
Lead sponsor
St. Joseph's Hospital, Florida
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2007
Completion date
December 31, 2010
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic to the liver